Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase

Arthritis and Rheumatism

Volumn 50, Issue 11, 2004, Pages 3702-3711

  Ross, Aron D ^a   Banda, Nirmal K ^b   Muggli, Michele ^b   Arend, William P ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN TYPE 2; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTHROPATHY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; HISTOPATHOLOGY; IN VITRO STUDY; JOINT; KNOCKOUT MOUSE; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STEADY STATE; WILD TYPE;

ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; CELLS, CULTURED; COLLAGEN TYPE II; EXTRACELLULAR FLUID; INTERFERON TYPE II; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; JOINTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIALOGLYCOPROTEINS; SPLEEN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 8444233946     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20593     Document Type: Article

References (47)

1. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146:857-68.
2. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
3. Trentham DE, Townes AS, Kang AH, David JR. Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest 1978;61:89-96.
4. Stuart JM, Townes AS, Kang AH. Collagen autoimmune arthritis [review]. Annu Rev Immunol 1984;2:199-218.
5. Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther 2003;5:R234-40.
6. McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 1974;185:529-31.
7. Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation: possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 2000;275:20069-76.
8. Burkhardt H, Schwingel M, Menninger H, Macartney HW, Tschesche H. Oxygen radicals as effectors of cartilage destruction: direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum 1986;29:379-87.
9. Mapp PI, Klocke R, Walsh DA, Chana JK, Stevens CR, Gallagher PJ, et al. Localization of 3-nitrotyrosine to rheumatoid and normal synovium. Arthritis Rheum 2001;44:1534-9.
10. Loeser RF, Carlson CS, Del Carlo M, Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1β and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum 2002;46:2349-57.
11. Sandhu JK, Robertson S, Birnboim HC, Goldstein R. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 2003;30:1173-81.
12. Bowler RP, Crapo JD. Oxidative stress in airways: is there a role for extracellular superoxide dismutase? [review]. Am J Respir Crit Care Med 2002;166:S38-43.
13. Marklund SL, Bjelle A, Elmqvist LG. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann Rheum Dis 1986;45:847-51.
14. Iyama S, Okamoto T, Sato T, Yamauchi N, Sato Y, Sasaki K, et al. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum 2001;44:2160-7.
15. Salvemini D, Mazzon E, Dugo L, Serraino I, De Sarro A, Caputi AP, et al. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum 2001;44:2909-21.
16. Dai L, Claxson A, Marklund SL, Feakins R, Yousaf N, Chernajovsky Y, et al. Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes. Gene Ther 2003;10:550-8.
17. Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci U S A 1995;92:6264-8.
18. Sheng H, Brady TC, Pearlstein RD, Crapo JD, Warner DS. Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci Lett 1999;267:13-6.
19. Sentman ML, Jonsson LM, Marklund SL. Enhanced alloxan-induced β-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase. Free Radic Biol Med 1999;27:790-6.
20. Jonsson LM, Edlund T, Marklund SL, Sandstrom T. Increased ozone-induced airway neutrophilic inflammation in extracellular-superoxide dismutase null mice. Respir Med 2002;96:209-14.
21. Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res 2003;93:622-9.
22. Bowler RP, Arcaroli J, Abraham E, Patel M, Chang LY, Crapo JD. Evidence for extracellular superoxide dismutase as a mediator of hemorrhage-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2003;284:L680-7.
23. Sentman ML, Brannstrom T, Westerlund S, Laukkanen MO, Yla-Herttuala S, Basu S, et al. Extracellular superoxide dismutase deficiency and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2001;21:1477-82.
24. Sentman ML, Brannstrom T, Marklund SL. EC-SOD and the response to inflammatory reactions and aging in mouse lung. Free Radic Biol Med 2002;32:975-81.
25. Thornton S, Duwel LE, Boivin GP, Ma Y, Hirsch R. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum 1999;42:1109-18.
26. Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, et al. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis. Arthritis Rheum 2001;44:451-62.
27. Banda NK, Kraus DM, Muggli M, Bendele A, Holers VM, Arend WP. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y. J Immunol 2003;171:2109-15.
28. Bendele AM, Chlipala ES, Scherrer J, Frazier J, Sennello G, Rich WJ, et al. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Arthritis Rheum 2000;43:2648-59.
29. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-20.
30. Blanco FJ, Geng Y, Lotz M. Differentiation-dependent effects of IL-1 and TGF-β on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J Immunol 1995;154:4018-26.
31. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
32. Vermeire K, Thielemans L, Matthys P, Billiau A. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-γ. J Leukoc Biol 2000;68:119-24.
33. Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases [review]. J Allergy Clin Immunol 2002;110:349-56.
34. Van de Loo FA, Bennink MB, Arntz OJ, Smeets RL, Lubberts E, Joosten LA, et al. Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. Am J Pathol 2003;163:1525-37.
35. Koga S, Ogawa S, Kuwabara K, Brett J, Leavy JA, Ryan J, et al. Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J Clin Invest 1992;90:1007-15.
36. Simeonova PP, Luster MI. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α response from alveolar macrophages. Am J Respir Cell Mol Biol 1995;12:676-83.
37. 2+. Inflamm Res 1999;48:544-9.
38. Schwartz MD, Repine JE, Abraham E. Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol 1995;12:434-40.
39. Parsey MV, Tuder RM, Abraham E. Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. J Immunol 1998;160:1007-13.
40. Garg AK, Aggarwal BB. Reactive oxygen intermediates in TNF signaling. Mol Immunol 2002;39:509-17.
41. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J Immunol 2004;172:2522-9.
42. Banda NK, Kraus D, Vondracek A, Huynh LH, Bendele A, Holers VM, et al. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Arthritis Rheum 2002;46:3065-75.
43. Banda NK, Vondracek A, Kraus D, Dinarello CA, Kim SH, Bendele A, et al. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol 2003;170:2100-5.
44. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis [review]. Arthritis Rheum 1990;33:305-15.
45. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis [review]. Arthritis Rheum 1995;38:151-60.
46. Arend WP. The balance between IL-1 and IL-1Ra in disease [review]. Cytokine Growth Factor Rev 2002;13:323-40.
47. Adarichev VA, Valdez JC, Bardos T, Finnegan A, Milkecz K, Giant TT. Combined autoimmune models of arthritis reveal shared and independent qualitative (binary) and quantitative trait loci. J Immunol 2003;170:2283-92.